
Filament Health posts $5M loss in 2024, faces liquidity concerns
Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) reported a net loss of $4.97 million for 2024 while the botanical psychedelic drug developer expanded its clinical trial programs and intellectual property portfolio. The Vancouver-based company announced …